Insilico Medicine and Qilu Pharmaceutical Group announced a strategic collaboration to jointly develop small-molecule inhibitors for cardiometabolic diseases, combining Insilico’s generative AI–driven ...
Viking Therapeutics, Inc. (NASDAQ:VKTX) is one of the best US stocks to buy under $50. On January 12, Viking Therapeutics, ...
GlobalData on MSN
FDA and EMA release collaborative AI framework for drug development
The joint guidance was created to ensure drug developers employ best practices when using AI.
CAMBRIDGE, Mass., Jan. 27, 2026 /PRNewswire/ -- Insilico Medicine, a clinical-stage biotechnology company powered by generative AI, and Qilu Pharmaceutical Group, a major comprehensive modern ...
Find out how NAMs are influencing safety assessments and decision-making in the pharmaceutical industry ahead of 2026.
The startup has partnered with Eli Lilly and enjoys the backing of some of Silicon Valley's most influential VCs.
The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...
A new analysis of drug trials used to approve medicines in the United States shows how far modern medicine still has to go to ...
Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...
Researchers have applied AI and machine learning to every stage of the drug development process. This includes identifying targets in the body, screening potential candidates, designing drug molecules ...
The Union Ministry of Health and Family Welfare has taken a series of measures including simplification of regulatory processes and reduction of drug approval timelines to facilitate and speed up the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results